Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2

NCT00398749 is registered in ClinicalTrials.gov with Janssen-Cilag B.V. as lead sponsor.

NCT NCT00398749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00398749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2
Lead sponsor
Janssen-Cilag B.V.
Phase
Observational
Overall status
Completed
Start date
October 31, 2005
Completion date
November 30, 2009
Enrollment
1,927 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, neoplasms